AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nu Skin Enterprises, Inc.

$4.79 -$4.89 (-50.52%)
NYSE · 15 Sep 2026 17:09 UTC
Previous Close
$4.87
Day Range
$4.72$4.82
Year Range
$4.49$14.62
Market Cap
232.8M
AVG Volume
674.28K
Trailing/Forward PE
-1.08/4.13
PEG ratio
-0.03
Dividend Yield
5.01%
Next Earnings Date
2026-11-05
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2320.11M
26 Q1320.61M
25 Q4370.32M
25 Q3364.21M
25 Q2386.14M
25 Q1364.49M
24 Q4445.55M
24 Q3430.14M
24 Q2439.08M
24 Q1417.31M
Net Income (USD)
-300M-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-249.8M
26 Q11.84M
25 Q414.49M
25 Q317.08M
25 Q221.12M
25 Q1107.52M
24 Q4-36.1M
24 Q38.3M
24 Q2-118.26M
24 Q1-533K
Operating Income (USD)
-150M-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-59.32M
26 Q15.87M
25 Q423.24M
25 Q321.64M
25 Q230.78M
25 Q1-9.9M
24 Q4-53.08M
24 Q318.23M
24 Q2-125.56M
24 Q18.82M
EBITDA (USD)
-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-47.2M
26 Q119.19M
25 Q435.1M
25 Q332.23M
25 Q242.99M
25 Q1152.09M
24 Q4-35.49M
24 Q337.12M
24 Q2-107.33M
24 Q126.86M
Cash Flows (USD)
-20M020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q24.99M
26 Q1-17.63M
25 Q45.86M
25 Q317.57M
25 Q235.78M
25 Q1-13.2M
24 Q413.2M
24 Q322.84M
24 Q243.08M
24 Q1-8.96M
EPS (USD)
-6-4-202424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-5.14
26 Q10.04
25 Q40.29
25 Q30.34
25 Q20.43
25 Q12.14
24 Q4-0.73
24 Q30.17
24 Q2-2.38
24 Q1-0.01
Expenses (USD)
0100M200M300M400MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2204.41M
26 Q1222.31M
25 Q4260.3M
25 Q3245M
25 Q2234.97M
25 Q1245.33M
24 Q4311.94M
24 Q3291.83M
24 Q2291.51M
24 Q1290.39M
Cash & Debt (USD)
0200M400M600MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2189.64M
26 Q1200.41M
25 Q4239.84M
25 Q3253M
25 Q2265.37M
25 Q1213.55M
24 Q4197.99M
24 Q3237.83M
24 Q2232.92M
24 Q1221.21M
Debt ratios
-20-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Debt ratios by quarter
PeriodDebt ratios
26 Q21.88
26 Q10.6
25 Q40.47
25 Q30.2
25 Q20.23
25 Q11.88
24 Q4-3.55
24 Q3-15.76
24 Q2-4.22
24 Q13.46
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Margins by quarter
PeriodMargins
26 Q268.2%
26 Q166.89%
25 Q470.74%
25 Q370.49%
25 Q268.82%
25 Q167.76%
24 Q462.65%
24 Q370.08%
24 Q269.96%
24 Q170.47%
Return on Capital
-60%-40%-20%0%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Return on Capital by quarter
PeriodReturn on Capital
26 Q2-46.03%
26 Q10.23%
25 Q41.8%
25 Q32.14%
25 Q22.68%
25 Q114.26%
24 Q4-5.54%
24 Q31.17%
24 Q2-17.23%
24 Q1-0.07%
Shares Outstanding
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q248.6M
26 Q148.2M
25 Q448.58M
25 Q349.4M
25 Q249.44M
25 Q149.76M
24 Q449.71M
24 Q349.71M
24 Q249.69M
24 Q149.54M
Dividends (USD)
00.511.5May 24Aug 24Nov 24Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
NUS Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.06
May 260.06
Feb 260.06
Nov 250.06
Aug 250.06
May 250.06
Feb 250.06
Nov 240.06
Aug 240.06
May 240.06
Employee Count
02K4K6K2016201720182019202020212022202320242025
NUS Employee Count by quarter
PeriodEmployee Count
20252.8K
20243.1K
20233.7K
20223.8K
20214.6K
20205K
20194.9K
20184.9K
20174.7K
20164.65K
Book Value Per Share (USD)
0510152024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q211.17
26 Q116.47
25 Q416.58
25 Q316.19
25 Q215.93
25 Q115.15
24 Q413.1
24 Q314.22
24 Q213.81
24 Q116.36
Total Assets (USD)
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NUS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q21.12B
26 Q11.38B
25 Q41.41B
25 Q31.42B
25 Q21.44B
25 Q11.39B
24 Q41.47B
24 Q31.58B
24 Q21.59B
24 Q11.74B
PE Ratio
020406080med 5.96Aug 23Dec 23Mar 24Sep 25Jan 26Apr 26Aug 26
NUS PE Ratio by quarter
PeriodPE Ratio
Aug 264.85
Jul 264.59
Jul 264.49
Jul 264.63
Jul 264.62
Jul 264.43
Jun 264.67
Jun 264.44
Jun 264.84
Jun 264.75
May 265.12
May 265.24
May 265.41
May 266.33
May 262.18
Apr 262.29
Apr 262.4
Apr 262.28
Apr 262.25
Mar 262.16
Mar 262.16
Mar 262.17
Mar 262.31
Feb 262.57
Feb 262.64
Feb 262.54
Feb 264.87
Jan 264.78
Jan 264.98
Jan 265.2
Jan 264.66
Jan 264.37
Dec 254.43
Dec 254.63
Dec 254.78
Dec 254.5
Nov 254.46
Nov 254.52
Nov 254.34
Nov 254.11
Oct 255.26
Oct 255.4
Oct 255.24
Oct 255.05
Oct 255.58
Sep 256
Sep 255.93
Sep 255.9
Sep 255.63
Aug 255.97
Aug 255.95
Aug 255.67
Aug 254.38
May 2471.34
Apr 2470.77
Apr 2474.79
Apr 2469.27
Apr 2471.98
Mar 2479.51
Mar 2470.71
Mar 2476.17
Mar 2473.24
Mar 2472.66
Feb 2472.32
Feb 2478.7
Feb 2414.99
Feb 2415.47
Jan 2415.98
Jan 2414.81
Jan 2415.44
Jan 2415.87
Dec 2316.54
Dec 2316.48
Dec 2316.48
Dec 2315.11
Dec 2314.96
Nov 2314.71
Nov 2315.33
Nov 2314.07
Nov 2315.33
Oct 2313.16
Oct 2313.9
Oct 2313.07
Oct 2313.81
Sep 2315.11
Sep 2316.58
Sep 2317.1
Sep 2316.53
Sep 2317.09
Aug 2316.93
Aug 2317.34
Aug 2317.94
Aug 2318.69
Jul 2319.18
Jul 2318.36
Jul 2318.86
Jul 2319.67
Jun 2321.28
Jun 2320.59
Jun 2321.49
Free Cash Flow Yield
0%10%20%30%40%med 14.87%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 264.56%
Sep 264.57%
Sep 264.58%
Aug 264.57%
Aug 264.68%
Aug 264.62%
Aug 2615.71%
Jul 2616.62%
Jul 2616.98%
Jul 2616.46%
Jul 2616.49%
Jul 2617.21%
Jun 2616.33%
Jun 2617.18%
Jun 2615.77%
Jun 2616.06%
May 2614.9%
May 2614.54%
May 2614.09%
May 2612.05%
May 2613.17%
Apr 2612.56%
Apr 2611.99%
Apr 2612.59%
Apr 2612.78%
Mar 2613.28%
Mar 2613.3%
Mar 2613.21%
Mar 2612.41%
Feb 2611.17%
Feb 2610.87%
Feb 2611.33%
Feb 269.99%
Jan 2610.18%
Jan 269.76%
Jan 269.36%
Jan 2610.46%
Jan 2611.15%
Dec 2510.98%
Dec 2510.52%
Dec 2510.18%
Dec 2510.82%
Nov 2510.92%
Nov 2510.78%
Nov 2511.23%
Nov 2511.84%
Oct 2511.06%
Oct 2510.76%
Oct 2511.09%
Oct 2511.52%
Oct 2510.43%
Sep 259.69%
Sep 259.81%
Sep 259.85%
Sep 2510.32%
Aug 259.74%
Aug 259.77%
Aug 2510.26%
Aug 2513.28%
Aug 2516.16%
Jul 2515.14%
Jul 2515.88%
Jul 2514.32%
Jul 2514.85%
Jun 2516.38%
Jun 2517.16%
Jun 2517.52%
Jun 2516.71%
May 2515.35%
May 2518.25%
May 2517.48%
May 2519.37%
May 2522.8%
Apr 2524.46%
Apr 2525.75%
Apr 2522.65%
Apr 2521.91%
Mar 2519.55%
Mar 2518.3%
Mar 2517.38%
Mar 2517.75%
Feb 2517.82%
Feb 2518.57%
Feb 2518.67%
Feb 2528.98%
Jan 2527.87%
Jan 2526.49%
Jan 2526.04%
Jan 2529.35%
Jan 2524.24%
Dec 2427%
Dec 2427.66%
Dec 2424.37%
Dec 2424.34%
Nov 2425.01%
Nov 2425.28%
Nov 2424.08%
Nov 2427.87%
Nov 2433.97%
Oct 2434.97%
Price to Sales
0.10.20.30.4med 0.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Price to Sales by quarter
PeriodPrice to Sales
Sep 260.17
Sep 260.17
Sep 260.17
Aug 260.17
Aug 260.17
Aug 260.17
Aug 260.18
Jul 260.17
Jul 260.17
Jul 260.18
Jul 260.17
Jul 260.17
Jun 260.18
Jun 260.17
Jun 260.18
Jun 260.18
May 260.19
May 260.2
May 260.2
May 260.24
May 260.24
Apr 260.25
Apr 260.26
Apr 260.25
Apr 260.24
Mar 260.23
Mar 260.23
Mar 260.23
Mar 260.25
Feb 260.28
Feb 260.28
Feb 260.27
Feb 260.34
Jan 260.34
Jan 260.35
Jan 260.37
Jan 260.33
Jan 260.31
Dec 250.31
Dec 250.33
Dec 250.34
Dec 250.32
Nov 250.31
Nov 250.32
Nov 250.3
Nov 250.29
Oct 250.33
Oct 250.34
Oct 250.32
Oct 250.31
Oct 250.35
Sep 250.37
Sep 250.37
Sep 250.37
Sep 250.35
Aug 250.37
Aug 250.37
Aug 250.35
Aug 250.27
Aug 250.24
Jul 250.26
Jul 250.25
Jul 250.27
Jul 250.26
Jun 250.24
Jun 250.23
Jun 250.22
Jun 250.24
May 250.26
May 250.22
May 250.22
May 250.2
May 250.18
Apr 250.17
Apr 250.16
Apr 250.18
Apr 250.18
Mar 250.21
Mar 250.22
Mar 250.23
Mar 250.23
Feb 250.23
Feb 250.22
Feb 250.22
Feb 250.18
Jan 250.18
Jan 250.19
Jan 250.2
Jan 250.17
Jan 250.21
Dec 240.19
Dec 240.18
Dec 240.21
Dec 240.21
Nov 240.2
Nov 240.2
Nov 240.21
Nov 240.18
Nov 240.17
Oct 240.17
EV/EBITDA
051015med 3.27Mar 24Jul 24Jul 25Nov 25Feb 26Jun 26Sep 26
NUS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 267.9
Sep 267.88
Sep 267.87
Aug 267.88
Aug 267.74
Aug 267.82
Aug 262.64
Jul 262.53
Jul 262.49
Jul 262.55
Jul 262.54
Jul 262.46
Jun 262.56
Jun 262.46
Jun 262.63
Jun 262.59
May 262.75
May 262.8
May 262.87
May 263.26
May 261.81
Apr 261.87
Apr 261.94
Apr 261.87
Apr 261.85
Mar 261.79
Mar 261.79
Mar 261.8
Mar 261.89
Feb 262.04
Feb 262.09
Feb 262.02
Feb 262.98
Jan 262.93
Jan 263.05
Jan 263.17
Jan 262.86
Jan 262.7
Dec 252.73
Dec 252.85
Dec 252.93
Dec 252.77
Nov 252.75
Nov 252.78
Nov 252.68
Nov 252.55
Oct 252.93
Oct 253
Oct 252.92
Oct 252.82
Oct 253.09
Sep 253.31
Sep 253.27
Sep 253.26
Sep 253.12
Aug 253.29
Aug 253.28
Aug 253.14
Aug 252.48
Aug 2510.67
Jul 2511.26
Jul 2510.82
Jul 2511.8
Jul 2511.45
Jun 2510.56
Jun 2510.16
Jun 259.99
Jun 2510.38
May 2511.14
May 259.67
May 2510.01
May 259.22
Aug 248.99
Jul 248.92
Jul 248.62
Jul 248.76
Jul 249.06
Jun 248.83
Jun 249.79
Jun 249.78
Jun 2410.2
May 2410.26
May 2410.2
May 2410.41
May 2410.19
May 248.92
Apr 248.87
Apr 249.2
Apr 248.75
Apr 248.97
Mar 249.57
Mar 248.87
Mar 249.31
Mar 249.07
Mar 249.02
Feb 249
Feb 249.51
Feb 248.29
Feb 248.48
Jan 248.69
Price/Operating Cashflow
02468med 3.91Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 264.66
Sep 264.64
Sep 264.63
Aug 264.64
Aug 264.53
Aug 264.59
Aug 263.48
Jul 263.29
Jul 263.22
Jul 263.32
Jul 263.32
Jul 263.18
Jun 263.35
Jun 263.18
Jun 263.47
Jun 263.41
May 263.67
May 263.76
May 263.88
May 264.54
May 264.35
Apr 264.56
Apr 264.78
Apr 264.55
Apr 264.48
Mar 264.31
Mar 264.31
Mar 264.34
Mar 264.62
Feb 265.13
Feb 265.27
Feb 265.06
Feb 265.97
Jan 265.86
Jan 266.11
Jan 266.37
Jan 265.7
Jan 265.35
Dec 255.43
Dec 255.67
Dec 255.86
Dec 255.51
Nov 255.46
Nov 255.53
Nov 255.31
Nov 255.04
Oct 255.67
Oct 255.83
Oct 255.66
Oct 255.45
Oct 256.02
Sep 256.48
Sep 256.4
Sep 256.37
Sep 256.08
Aug 256.44
Aug 256.42
Aug 256.12
Aug 254.73
Aug 253.75
Jul 254
Jul 253.81
Jul 254.23
Jul 254.08
Jun 253.7
Jun 253.53
Jun 253.46
Jun 253.63
May 253.95
May 253.32
May 253.47
May 253.13
May 252.75
Apr 252.57
Apr 252.44
Apr 252.77
Apr 252.87
Mar 253.21
Mar 253.43
Mar 253.61
Mar 253.54
Feb 253.52
Feb 253.38
Feb 253.36
Feb 252.23
Jan 252.32
Jan 252.44
Jan 252.49
Jan 252.21
Jan 252.67
Dec 242.4
Dec 242.34
Dec 242.66
Dec 242.66
Nov 242.59
Nov 242.56
Nov 242.69
Nov 242.32
Nov 241.97
Oct 241.92
Price to Book
0.20.40.60.8med 0.51Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Price to Book by quarter
PeriodPrice to Book
Sep 260.44
Sep 260.43
Sep 260.43
Aug 260.43
Aug 260.42
Aug 260.43
Aug 260.33
Jul 260.32
Jul 260.31
Jul 260.32
Jul 260.32
Jul 260.3
Jun 260.32
Jun 260.3
Jun 260.33
Jun 260.33
May 260.35
May 260.36
May 260.37
May 260.43
May 260.43
Apr 260.45
Apr 260.48
Apr 260.45
Apr 260.45
Mar 260.43
Mar 260.43
Mar 260.43
Mar 260.46
Feb 260.51
Feb 260.53
Feb 260.5
Feb 260.67
Jan 260.66
Jan 260.68
Jan 260.71
Jan 260.64
Jan 260.6
Dec 250.61
Dec 250.63
Dec 250.66
Dec 250.62
Nov 250.61
Nov 250.62
Nov 250.59
Nov 250.56
Oct 250.67
Oct 250.69
Oct 250.67
Oct 250.65
Oct 250.71
Sep 250.77
Sep 250.76
Sep 250.76
Sep 250.72
Aug 250.76
Aug 250.76
Aug 250.73
Aug 250.56
Aug 250.54
Jul 250.58
Jul 250.55
Jul 250.61
Jul 250.59
Jun 250.53
Jun 250.51
Jun 250.5
Jun 250.52
May 250.57
May 250.48
May 250.5
May 250.45
May 250.47
Apr 250.44
Apr 250.42
Apr 250.48
Apr 250.49
Mar 250.55
Mar 250.59
Mar 250.62
Mar 250.61
Feb 250.6
Feb 250.58
Feb 250.58
Feb 250.44
Jan 250.46
Jan 250.48
Jan 250.49
Jan 250.44
Jan 250.53
Dec 240.48
Dec 240.46
Dec 240.53
Dec 240.53
Nov 240.51
Nov 240.51
Nov 240.53
Nov 240.46
Nov 240.46
Oct 240.45
Nu Skin Enterprises, Inc.
NUS
Stockpicker

Video analysis: NUS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NUS

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

businesswire.com · 3 Sep 2026

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the third consecutive year.* “Being recognized by Euromonitor is a powerful validation of our long-term vision and commitment to innovation,” said Ryan Napierski, Nu Skin president and CEO. “We believe the future of wellness will be increasingly personalized, intelligent and.

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

gurufocus.com · 3 Sep 2026

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 company for beauty and wellness device systems by E

STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push

zacks.com · 25 Aug 2026

STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push

STM and NUS launch a four-year lab to advance low-power edge AI for robots, humanoids and drones using local processing and P18 FD-SOI technology.

STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore

globenewswire.com · 24 Aug 2026

STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore

STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore HELIX joint R&D initiative to enable new generative and embodied AI use cases at the edge through system-to-silicon innovation Research will focus on memory-centric architectures, innovative in-memory computing, scalable compute-and-memory systems, and advanced silicon and embedded-memory technologies Corporate Lab will strengthen Singapore's advanced semiconductor research capabilities and support the development of future edge AI talent and innovation Singapore, 24 August 2026 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, and the National University of Singapore (NUS) have officially launched the ST–NUS HELIX Corporate Lab, a four-year strategic research initiative focused on advancing the next generation of edge AI technologies.

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

newsfilecorp.com · 11 Aug 2026

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

Dallas, Texas--(Newsfile Corp. - August 11, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.1M, $10.0M, and $0.20, respectively.

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

zacks.com · 11 Aug 2026

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

NUS' second-quarter revenues fall 17.1% and EPS drops 53.5%, while it cuts the 2026 revenue and adjusted EPS outlooks.

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

seekingalpha.com · 11 Aug 2026

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Nu Skin Enterprises Q2 Earnings Call Highlights

marketbeat.com · 11 Aug 2026

Nu Skin Enterprises Q2 Earnings Call Highlights

Nu Skin Enterprises NYSE: NUS reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, as the company continued the rollout of its Prysm iO wellness platform and pursued cost and margin initiatives.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.